Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis.

Arthritis, Rheumatoid / diagnosis Humans Observational Studies as Topic Outcome Assessment, Health Care Severity of Illness Index
OBSERVATIONAL STUDIES OMERACT OUTCOME ASSESSMENT REGISTRIES RHEUMATOID ARTHRITIS

Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
09 2019
Historique:
accepted: 18 12 2018
pubmed: 3 3 2019
medline: 21 10 2020
entrez: 3 3 2019
Statut: ppublish

Résumé

This is an update from the Outcome Measures in Rheumatology (OMERACT) Core Outcomes in Longterm Observational Studies Special Interest Group with a focus on rheumatoid arthritis. Preliminary data and proposed next steps were outlined and discussed by participants. Domains identified after initial steps (systematic review and qualitative research) were pain, physical functioning, participation (i.e., work, social), longterm symptoms, fertility/family planning, emotional well-being, coping, financial status, and adverse events including death. The group agreed conceptually that short-term core outcomes could be different from longer term ones. Participants emphasized the importance of analyzing the need for core domains specifically for longterm longitudinal observational studies.

Identifiants

DOI: 10.3899/jrheum.181076 PMID: 30824644
pubmed: 30824644
pii: jrheum.181076
doi: 10.3899/jrheum.181076
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1164-1167

Auteurs

Maria A Lopez-Olivo (MA)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0002-5165-8393

José B Negrón (JB)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0003-4659-5508

Richard J Zogala (RJ)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.

Loreto Carmona (L)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0002-4401-2551

Karla Criner (K)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.

Niti Goel (N)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0001-5869-5157

Laura Gonzalez-Lopez (L)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0002-6517-6344

Francesca Ingegnoli (F)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0002-6727-1273

Amye Leong (A)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0002-9948-7407

Lyn March (L)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0003-1736-8111

Beverly Shea (B)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.

Vibeke Strand (V)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0003-4978-4072

Peter Tugwell (P)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0001-5062-0556

Tiffany Westrich-Robertson (T)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.

Natalia V Zamora (NV)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.

Robin Christensen (R)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
ORCID: 0000-0002-6600-0631

Maria E Suarez-Almazor (ME)

From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark. msalmazor@mdanderson.org.
M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. msalmazor@mdanderson.org.
ORCID: 0000-0001-5381-5797

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Polyarthrite rhumatoïde › Core Outcome Sets Specifically for Longterm...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Core Outcome Sets Specifically for Longterm...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Études observationnelles comme sujet › Core Outcome Sets Specifically for Longterm...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Core Outcome Sets Specifically for Longterm...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Indicateurs d'état de santé › Acuité des besoins du patient › Indice de gravité de la maladie › Core Outcome Sets Specifically for Longterm...